Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010


#41790

53pages

GlobalData

$ 1000

In Stock


GlobalData's clinical trial report, “Central Nervous System Tumors Global Clinical Trials Review, Q4, 2010"" provides data on the Central Nervous System Tumors clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Central Nervous System Tumors. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Central Nervous System Tumors). 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

1. Table of Contents

1. Table of Contents 2
1.1. List of Tables 5
1.2. List of Figures 7

2. Introduction 8
2.1. Central Nervous System (CNS) Tumors 8
2.2. Report Guidance 8

3. Clinical Trials by Region 9
3.1. Clinical Trials by Country 10
3.1.1. Top Countries Contributing to Clinical Trials in Asia-Pacific 12
3.1.2. Top Five Countries Contributing to Clinical Trials in Europe 13
3.1.3. Top Countries Contributing to Clinical Trials in North America 14
3.1.4. Top Countries Contributing to Clinical Trials in Central and South America 15
3.2. Clinical Trials by BRIC Countries 16
3.2.1. Clinical Trials by Phase 17
3.3. In Progress Trials by Phase 18

4. Clinical Trials by Trial Status 19
4.1. Unaccomplished Trials of CNS Tumors 20

5. Subjects Recruited Over a Period of Time 22
5.1. Enrollment Trends by Phase for the Last Decade 23

6. Prominent Sponsors 24
6.1. Top 10 Companies Participating in CNS Tumors Clinical Trials 26

7. Prominant Drug Comparison 28

8. Clinical Trial Profiles 29

8.1. Clinical Trial Overview of Top Companies 29
8.1.1. Astellas Pharma Inc. 29
8.1.2. Burzynski Research Institute, Inc. 29
8.1.3. Children's Oncology Group 30
8.1.4. Clatterbridge Centre for Oncology NHS Foundation Trust 30
8.1.5. Daiichi Sankyo, Inc. 31
8.1.6. Eli Lilly and Company 31
8.1.7. Neurocrine Biosciences, Inc. 31
8.1.8. Pediatric Brain Tumor Consortium 32
8.1.9. Peregrine Pharmaceuticals, Inc. 32
8.1.10. Pfizer Inc. 32
8.1.11. St. Jude Childrens Research Hospital, Inc. 33
8.1.12. Trans Tasman Radiation Oncology Group 33
8.2. Clinical Trial Overview of Top Universities / Institutes / Hospitals 34
8.2.1. National Cancer Institute (NCI) 34
8.2.2. Duke University 37
8.2.3. Memorial Sloan Kettering Cancer Center 38
8.2.4. European Organization for Research and Treatment of Cancer 39
8.2.5. University of California, Los Angeles 40
8.2.6. UCLA's Jonsson Comprehensive Cancer Center 41
8.2.7. The University of Texas M. D. Anderson Cancer Center 42
8.2.8. Children's Oncology Group 43
8.2.9. New York University School of Medicine 44
8.2.10. Mayo Clinic 44
8.2.11. Sidney Kimmel Comprehensive Cancer Center 45
8.2.12. North Central Cancer Treatment Group 45
8.2.13. Cancer Research UK 46
8.2.14. University of Wisconsin Madison 46
8.2.15. Osaka Medical College 47
8.2.16. Radiation Therapy Oncology Group 47
8.2.17. Massachusetts General Hospital 48
8.2.18. Barbara Ann Karmanos Cancer Institute 48
8.2.19. Pediatric Brain Tumor Consortium 49
8.2.20. University of Florida 49

9. Appendix 50
9.1. Abbreviations 50
9.2. Definitions 50
9.3. Research Methodology 51
9.4. Secondary Research 51
9.5. About GlobalData 52
9.6. Contact Us 52
9.7. Disclaimer 52
9.8. Source 53
Table 1: CNS Tumors Therapeutics Market, Global, Clinical Trials by Zone (%), 2010*
Table 2: CNS Tumors Clinical Trials In Progress by Top Countries, 1982-2010*
Table 3: CNS Tumors Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2010*
Table 4: CNS Tumors Therapeutics Clinical Trials, Europe, Top Five Countries, 2010*
Table 5: CNS Tumors Therapeutics Clinical Trials, North America, Top Countries, 2010*
Table 6: CNS Tumors Therapeutics Clinical Trials, Central and South America, Top Countries, 2010*
Table 7: CNS Tumors Therapeutics Clinical Trials, BRIC Countries, 2010*
Table 8: CNS Tumors Therapeutics Market, Global, Clinical Trials by Phase, 2010*
Table 9: CNS Tumors Therapeutics Market, Global, Clinical Trials by Phase, 2010*
Table 10: CNS Tumors Therapeutics Market, Global, Clinical Trials by Trial Status, 2010*
Table 11: CNS Tumors Therapeutics Market, Global, Suspended Clinical Trials, 2010*
Table 12: CNS Tumors Therapeutics Market, Global, Terminated Clinical Trials, 2010*
Table 13: CNS Tumors Therapeutics Market, Global, Withdrawn Clinical Trials, 2010*
Table 14: CNS Tumors Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009
Table 15: CNS Tumors Therapeutics Clinical Trials, Global, Enrollment Target Trends by Phase and Year, 2001-2010*
Table 16: CNS Tumors Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
Table 17: CNS Tumors Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010*
Table 18: CNS Tumors Therapeutics Clinical Trials, Global, Clinical Trials in Progress by Prominent Drugs, 2010*
Table 19: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2010*
Table 20: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2010*
Table 21: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2010*
Table 22: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Clatterbridge Centre for Oncology NHS Foundation Trust, 2010*
Table 23: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2010*
Table 24: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2010*
Table 25: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2010*
Table 26: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Pediatric Brain Tumor Consortium, 2010*
Table 27: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Peregrine Pharmaceuticals, Inc., 2010*
Table 28: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2010*
Table 29: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2010*
Table 30: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Trans Tasman Radiation Oncology Group, 2010*
Table 31: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 2010*
Table 32: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2010*
Table 33: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2010*
Table 34: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2010*
Table 35: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2010*
Table 36: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2010*
Table 37: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2010*
Table 38: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2010*
Table 39: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2010*
Table 40: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2010*
Table 41: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2010*
Table 42: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2010*
Table 43: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2010*
Table 44: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2010*
Table 45: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka Medical College, 2010*
Table 46: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2010*
Table 47: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2010*
Table 48: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2010*
Table 49: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Pediatric Brain Tumor Consortium, 2010*
Table 50: CNS Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2010*

Figure 1: CNS Tumors Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 9
Figure 2: CNS Tumors Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 10
Figure 3: CNS Tumors Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2010* 11
Figure 4: CNS Tumors Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2010* 12
Figure 5: CNS Tumors Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 13
Figure 6: CNS Tumors Therapeutics Clinical Trials, North America, Top Countries (%), 2010* 14
Figure 7: CNS Tumors Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 17
Figure 8: CNS Tumors Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 18
Figure 9: CNS Tumors Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 19
Figure 10: CNS Tumors Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 22
Figure 11: CNS Tumors Therapeutics Clinical Trials, Global, Enrollment Target Trends by Phase and Year, 2001-2010* 23
Figure 12: CNS Tumors Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 24
Figure 13: CNS Tumors Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 26
Figure 14: CNS Tumors Therapeutics Clinical Trials, Global, Clinical Trials in Progress by Prominent Drugs, 2010* 28
Figure 15: GlobalData Methodology 51